Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6140972 | 6836297 | F | 2 | 6140972-0 | 20081117 | 20090326 | 20090331 | EXP | SP02137 | SALIX PHARMACEUTICALS, INC. | 55 | YR | M | N | 20090330 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6140972 | 1011367913 | PS | VISICOL | 1 | ORAL | (50 GM), ORAL | D | D | 21097 | ||
| 6140972 | 1011409065 | C | AZELNIDIPINE | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6140972 | 1011367913 | COLONOSCOPY |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6140972 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6140972 | BLOOD CREATININE INCREASED |
| 6140972 | BLOOD UREA INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6140972 | FGN |
| 6140972 | HP |
| 6140972 | OTH |
| 6140972 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6140972 | 1011367913 | 20081111 | 20081111 |